Onychocryptosis: a retrospective study of clinical aspects, inflammation treatment and pain management using Ozoile as a hydrogel and cream formulation
https://doi.org/10.4081/ejtm.2024.12487
Accepted: 9 May 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Ingrown toenails account for roughly 20% of all foot problems in primary care. It is most common in young men, with nail care habits and footwear being major contributors. Onychocryptosis is typically caused by self-treatment attempts to cure the condition in its early stages. Its clinical features are frequently confused with other osseous and soft tissue abnormalities. The goal of this study was to provide perspectives on the management of pain and inflammation in Onychocryptosis using an Ozoile-based hydrogel formulation in a semi-occlusive bandage for 14 days, while incorporating natural pharmacological solutions into established protocols. The primary outcomes measured were pain reduction on NRS and stadiation according to the Al Kline Classification. The reduction was statistically significant, with a mean decrease in VAS score from 10 to 4 (p < 0.05), and Al Kline classification decreased by an average of 1.6 stages. 42% of patients recovered within the first 15 days of treatment, and 93% by the end of the scheduled treatment.
Mayeaux EJ Jr, Carter C, Murphy TE. Ingrown toenail management. Am Fam Physician 2019;100:158-64.
Khunger N, Kandhari R. Ingrown toenails. Indian J Dermatol Venereol Leprol 2012;78:279-89. DOI: https://doi.org/10.4103/0378-6323.95442
Arica IE, Bostanci S, Kocyigit P, Arica DA. Clinical and sociodemographic characteristics of patients with ingrown nails. J Am Podiatr Med Assoc 2019;109:201-6. DOI: https://doi.org/10.7547/17-023
Haneke E. Controversies in the treatment of ingrown nails. Dermatol Res Pract 2012;2012:783924. DOI: https://doi.org/10.1155/2012/783924
Erdogan FG, Guven M, Erdogan BD, Gurler A. Previous nail surgery is a risk factor for recurrence of ingrown nails. Dermatol Surg 2014;40:1152-4. DOI: https://doi.org/10.1097/01.DSS.0000452651.44883.c1
Yang G, Yanchar NL, Lo AY, Jones SA. Treatment of ingrown toenails in the pediatric population. J Pediatr Surg 2008;43:931-5. DOI: https://doi.org/10.1016/j.jpedsurg.2007.12.042
Pico AM, Verjano E, Mayordomo R. Relation between nail consistency and incidence of ingrown toenails in young male runners. J Am Podiatr Med Assoc 2017;107:137-43. DOI: https://doi.org/10.7547/15-121
Vural S, Bostanci S, Kocyigit P, et al. Risk factors and frequency of ingrown nails in adult diabetic patients. J Foot Ankle Surg 2018;57:289-95. DOI: https://doi.org/10.1053/j.jfas.2017.10.006
Heidelbaugh JJ, Lee H. Management of the ingrown toenail. Am Fam Physician 2009;79:303-8.
Borges APP, Pelafsky VPC, Miot LDB, Miot HA. Quality of life with ingrown toenails: a cross-sectional study. Dermatol Surg 2017;43:751-3. DOI: https://doi.org/10.1097/DSS.0000000000000954
Pawlik P, Zaroda P, Dąda P, et al. Onychocryptosis: a review of epidemiology, risk factors, classification, complications and effective therapeutic strategies. J Educ Health Sport 2024;55:199-216. DOI: https://doi.org/10.12775/JEHS.2024.55.013
De Lauro NM, De Lauro TM. Onychocryptosis. Clin Podiatr Med Surg 2004;21:617-30, vii.
Moellhoff N, Polzer H, Baumbach SF, et al. Unguis incarnatus – konservative oder operative Therapie? Ein praktischer Behandlungsalgorithmus [Unguis incarnatus-conservative or operative treatment? A practical treatment algorithm]. Unfallchirurg 2021;124:311-318. German. DOI: https://doi.org/10.1007/s00113-020-00903-6
Currò M, Russo T, Ferlazzo N, et al. Anti-infiammatory and tissue regenerative effects of topical treatment with ozonated olive oil/vitamin E acetate in balanitis xerotica obliterans. Molecules 2018;23:645. DOI: https://doi.org/10.3390/molecules23030645
Russo T, Currò M, Ferlazzo N, et al. Stable ozonides with vitamin E acetate versus corticosteroid in the treatment of lichen sclerosus in foreskin: evaluation of effects on infiammation. Urol Int 2019;103:459-65. DOI: https://doi.org/10.1159/000499846
Di Maria D. New therapeutic approach with Ozoile® to the EAC eczema, a chronic and annoying pathology. J Otolaryngol ENT Res 2020;12:32-5. DOI: https://doi.org/10.15406/joentr.2020.12.00452
Al Kline DPM. Onychocryptosis: a simple classification system. Foot Ankle J 2008;1:6. DOI: https://doi.org/10.3827/faoj.2008.0106.0004
Ricci E, Pittarello M, Giacinto F. Studio di valutazione del presidio Rigenoma con Ozoile® nel trattamento di lesioni cutanee croniche. Ital J Wound Care 2022;6:90. DOI: https://doi.org/10.4081/ijwc.2022.90
Zagolin G, Loss G, Tasinato M, et al. Advantages of the topical application of ozoile® in the healing of venous ulcers of the lower limbs. A randomized clinical study. Biomed J Sci Tech Res 2022;47:7516. DOI: https://doi.org/10.26717/BJSTR.2022.47.007516
Chabchoub I, Litaiem N. Ingrown toenails. 2022 Sep 18. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31536303.
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
